Rare diseases
Investigational molecules
Locations
Recruiting trials first
4 clinical trials in this condition
Long-Term Safety and Efficacy of Lebrikizumab in Children and Adolescents With Moderate-to-Severe Atopic Dermatitis
CzechiaStudy on the Safety and Effectiveness of Metal Panel Allergens for Diagnosing Allergic Contact Dermatitis and Eczema in Patients
GermanyStudy of Lebrikizumab and Topical Corticosteroids for Children and Teens with Moderate-to-Severe Atopic Dermatitis
CzechiaStudy on the Effect of a New Moisturiser with Paraffin and Liquid Paraffin on Preventing Eczema Relapse in Children
GermanyIn short
Identifying eczema begins with understanding the symptoms that affect your skin, and knowing when to seek medical guidance can help you manage this common condition more effectively.
If you notice persistent itchy, dry, or inflamed patches on your skin, it may be time to consider seeking a medical evaluation for eczema. This condition affects more than 31 million Americans and can appear at any age, though it most commonly begins in childhood. Anyone experiencing recurring skin symptoms that disrupt daily life or interfere with sleep should consider consulting a healthcare provider for proper assessment.
Diagnostic evaluation becomes especially important when skin symptoms persist despite basic skincare efforts, or when the rash appears suddenly and worsens quickly. People who have a family history of allergies, asthma, or hay fever are at higher risk for developing eczema and may benefit from earlier diagnostic attention. Children whose symptoms begin before age five, as well as adults who develop new skin problems, should undergo evaluation to determine whether eczema or another skin condition is responsible for their discomfort.
Seeking diagnostics promptly helps distinguish eczema from other skin conditions that may look similar but require different treatments. Early identification allows for better symptom management and can prevent complications such as skin infections that may develop from scratching. Understanding what causes your symptoms and which type of eczema you have enables you and your healthcare provider to develop a tailored management plan that addresses your specific needs.
Diagnosing eczema primarily relies on a thorough clinical evaluation rather than a single definitive test. Your healthcare provider will begin by talking with you about your symptoms, examining your skin carefully, and reviewing your complete medical history. This conversation-based approach helps the doctor understand when your symptoms started, what makes them better or worse, and whether similar conditions run in your family.
During the physical examination, your healthcare provider will look at the appearance, location, and pattern of your rash. The way eczema presents can vary significantly depending on your skin tone. For people with lighter skin, eczema typically appears as pink, red, or purple patches. For those with darker skin tones, the rash may look purple, brown, gray, or darker than the surrounding skin. The doctor will also check whether your skin shows characteristic signs such as dryness, thickening, scaling, or areas where scratching has damaged the skin.
The location of your symptoms provides important diagnostic clues. In infants, eczema commonly affects the face, scalp, and the outer surfaces of the arms and legs. In older children, teenagers, and adults, the condition typically appears in the creases of elbows and behind the knees, as well as on the neck, wrists, ankles, and hands. Recognizing these patterns helps distinguish eczema from other skin conditions that affect different body areas.
Your medical history plays a crucial role in diagnosis. Healthcare providers will ask whether you or close family members have been diagnosed with eczema, asthma, hay fever, or allergies. This information matters because eczema often runs in families and frequently occurs alongside these other conditions. The presence of these related conditions increases the likelihood that your skin symptoms represent atopic dermatitis, which is the most common type of eczema and refers to a form of skin inflammation linked to allergic tendencies.
While eczema itself is not an allergy, allergens can trigger flare-ups in some people. When your healthcare provider suspects that allergies may be contributing to your eczema symptoms, they might recommend allergy testing. This testing helps identify specific substances that could be making your condition worse, such as certain foods, pet dander, dust mites, or pollen.
One common diagnostic approach is patch testing, which is performed on your skin to identify allergies. During this test, small amounts of different substances are applied to your skin and then covered. Over the next few days, your doctor examines your skin for signs of a reaction to any of these substances. This method is particularly helpful for diagnosing contact dermatitis, a type of eczema that develops when your skin reacts to specific materials or chemicals it touches.
Your healthcare provider might also consider food allergy testing if they suspect certain foods trigger your symptoms. This is especially relevant for children with eczema, as the condition is associated with the development of food allergies. However, food allergies do not cause eczema in everyone, and removing foods from your diet should only be done under medical guidance.
An important part of the diagnostic process involves ruling out other skin conditions that can look similar to eczema. Conditions like psoriasis, which causes inflamed, scaly skin patches, can sometimes be confused with eczema, making accurate diagnosis essential. Your healthcare provider uses the combination of symptom patterns, skin appearance, personal history, and family history to differentiate between these conditions.
Sometimes, particularly when the diagnosis is unclear or when initial treatments are not working, your doctor might perform a skin biopsy. This procedure involves removing a small sample of skin tissue for examination under a microscope. While not routinely needed for eczema diagnosis, a biopsy can help exclude other skin diseases that require different treatment approaches.
When patients consider participating in clinical trials for eczema treatments, they typically undergo more extensive diagnostic evaluations than those used in routine clinical practice. These assessments serve to confirm the diagnosis, measure the severity of disease, and determine whether the patient meets specific criteria for enrollment in the study.
Clinical trials often require objective measurements of eczema severity using standardized assessment tools. Healthcare providers evaluate the extent of skin involvement by calculating what percentage of the body surface area shows eczema symptoms. They also assess factors such as redness, thickness, scratching, and the intensity of itching using validated scoring systems. These measurements help researchers track whether new treatments are working and allow comparison of results across different studies.
Blood tests may be performed as part of clinical trial screening to check overall health status and rule out conditions that might interfere with the study. These tests can measure various factors including immune system markers, inflammation levels, and general organ function. Some trials specifically measure levels of immunoglobulin E (IgE), an antibody associated with allergic conditions, as elevated IgE is common in people with atopic dermatitis.
Clinical trials for moderate to severe eczema may include additional diagnostic procedures to establish baseline measurements before treatment begins. These might involve taking photographs of affected skin areas to document changes over time, collecting small skin samples for laboratory analysis, or performing specialized tests to measure skin barrier function. Such thorough documentation helps researchers understand exactly how new therapies affect the skin at both visible and microscopic levels.
Allergy testing takes on particular importance in some clinical trial settings. Since many eczema treatments target specific aspects of the immune response or inflammation pathways, researchers may need to know whether participants have particular allergies or sensitivities. This information helps determine whether someone is eligible for a specific trial and assists in interpreting the results of the treatment being studied.
Trial participation may also require screening for skin infections before enrollment. Since people with eczema have a weakened skin barrier, they are more susceptible to bacterial, viral, or fungal infections. Researchers need to ensure that any symptoms are due to eczema itself rather than an active infection, as infections could affect how well a treatment appears to work and might pose safety concerns for participants.
Eczema is a long-lasting condition that tends to come and go in episodes called flare-ups. The outlook varies considerably from person to person. Many children who develop eczema in infancy show significant improvement as they grow older, with nearly half outgrowing the condition or experiencing substantial symptom reduction by adulthood. The disease often gets better over time and may even disappear completely for extended periods.
However, for some individuals, eczema remains a persistent challenge throughout adulthood. When symptoms continue into adult years, the condition is typically chronic, meaning it requires ongoing management rather than offering a complete cure. The severity and frequency of flare-ups can be influenced by many factors including identifying and avoiding personal triggers, following proper skincare routines, and using appropriate treatments when symptoms appear.
People with eczema face an increased risk of developing other allergic conditions. The progression from eczema in infancy to food allergies, followed by allergic rhinitis and asthma, follows a pattern called the atopic march. Understanding this connection helps healthcare providers monitor patients for these related conditions and intervene early when necessary.
The impact on quality of life depends largely on how well the condition is managed. Severe itching can disrupt sleep and concentration, and visible rashes may affect emotional wellbeing and social interactions. However, with proper treatment, most people can effectively manage their symptoms and prevent serious flare-ups. Taking good care of your skin, using medications as prescribed, and avoiding known irritants can help minimize symptoms and allow people with eczema to live fulfilling, active lives.
Eczema is not a life-threatening condition, and discussions of survival rates do not apply to this skin disorder. While eczema can significantly affect quality of life and may lead to complications such as skin infections if not properly managed, it does not reduce life expectancy. The primary health concerns relate to symptom management, preventing complications, and addressing the psychological and social impacts of living with a chronic skin condition.
This guide is here to help you understand the condition. It does not replace a conversation with your doctor, who knows your situation best.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
